Physician

Albert Tartini, M.D.

According to 2025 Medicare claims, Albert Tartini, M.D. (NPI: 1346240298) practices nephrology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is EXCELCARE MEDICAL ASSOCIATES, PA (NPI: 1992736300; TIN: 203130405) and primary practice location at 07652-1466. Tartini is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Tartini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 381 traditional Medicare patients, billed 2,724 HCPCS/CPT codes, and received $187,303 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,321 prescription claims across 186 beneficiaries totaling $739,987 in drug costs, led by Gattex (Teduglutide). DME data shows 26 claims. Open Payments data shows 16 records totaling $400. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $247,380 to $187,303. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $292,269 and ending at $739,987. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	474	3,499	$247,380
2016	446	2,664	$197,090
2017	483	4,003	$225,446
2018	443	2,675	$228,895
2019	422	3,129	$227,217
2020	356	2,929	$186,131
2021	366	7,352	$220,414
2022	308	3,427	$135,896
2023	341	3,169	$161,001
2024	381	2,724	$187,303

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	173	1,534	$292,269
2016	168	1,403	$380,455
2017	161	1,375	$398,069
2018	171	1,418	$212,995
2019	163	1,360	$301,250
2020	156	1,371	$703,394
2021	181	1,431	$263,628
2022	159	1,309	$226,200
2023	167	1,265	$672,168
2024	186	1,321	$739,987

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$400
2019	N/R	N/R	N/R
2020	N/R	33	$801
2021	N/R	N/R	N/R
2022	N/R	36	$429
2023	N/R	65	$872
2024	N/R	26	$248

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	88	103	$151
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	109	211	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	167	389	$74
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	115	276	$69
90935	Hemodialysis procedure with physician evaluation	42	109	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gattex	Teduglutide	12	360	$547,439
Velphoro	Sucroferric Oxyhydroxide	27	1,290	$77,865
Januvia	Sitagliptin Phosphate	18	1,140	$16,460
Kerendia	Finerenone	12	840	$16,195
Auryxia	Ferric Citrate	13	750	$12,599

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	14	$98

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$400	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert Tartini, M.D.?

Tedicare shows public-source Medicare data for Albert Tartini, M.D. (NPI 1346240298), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert Tartini, M.D. have ACO affiliation data?

Albert Tartini, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Albert Tartini, M.D.?

Albert Tartini, M.D. is linked to EXCELCARE MEDICAL ASSOCIATES, PA (billing NPI 1992736300) in the available physician profile data.

Does Albert Tartini, M.D. have Open Payments data?

Albert Tartini, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.